Cargando…
Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC
Obesity is a major driver of cancer, especially hepatocellular carcinoma (HCC). The prevailing view is that non-alcoholic steatohepatitis (NASH) and fibrosis or cirrhosis are required for HCC in obesity. Here, we report that NASH and fibrosis and HCC in obesity can be dissociated. We show that the o...
Autores principales: | Grohmann, Marcus, Wiede, Florian, Dodd, Garron T., Gurzov, Esteban N., Ooi, Geraldine J., Butt, Tariq, Rasmiena, Aliki A., Kaur, Supreet, Gulati, Twishi, Goh, Pei K., Treloar, Aislinn E., Archer, Stuart, Brown, Wendy A., Muller, Mathias, Watt, Matthew J., Ohara, Osamu, McLean, Catriona A., Tiganis, Tony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242467/ https://www.ncbi.nlm.nih.gov/pubmed/30454647 http://dx.doi.org/10.1016/j.cell.2018.09.053 |
Ejemplares similares
-
T-Cell Protein Tyrosine Phosphatase Attenuates STAT3 and Insulin Signaling in the Liver to Regulate Gluconeogenesis
por: Fukushima, Atsushi, et al.
Publicado: (2010) -
The paradox of immunotherapy in NASH-HCC
por: Peng, Yao, et al.
Publicado: (2021) -
Favorable prognostic role of IL-26 in HCC patients associated with JAK-STAT3-dependent autophagy
por: Zhao, Qihong, et al.
Publicado: (2021) -
CXCR2 inhibition enables NASH-HCC immunotherapy
por: Leslie, Jack, et al.
Publicado: (2022) -
Mitochondrial Dysfunction in the Transition from NASH to HCC
por: Léveillé, Mélissa, et al.
Publicado: (2019)